Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Polymorphic crystal forms of 5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-1-(R)-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one, heminapadisytlate as agonist of the β2 adrenergic receptor

US Patent 9346759 · Granted May 24, 2016

Assignee

Inventors

View full patent text on Google Patents →